Shuping Li

1.5k citations
71 papers · 1.1k indexed · h-index 20
Topics
Cancer-related molecular mechanisms research (8 papers)Circular RNAs in diseases (8 papers)MicroRNA in disease regulation (7 papers)
Partner nations
ChinaUnited StatesJapan

In The Last Decade

Shuping Li

67 papers receiving 1.1k citations

Peers

Shuping Li
Comparison fields: 5 of 98
  • Molecular Biology 778
  • Cancer Research 348
  • Immunology 129
  • Pulmonary and Respiratory Medicine 118
  • Oncology 99
Replace Donghwan Kim with:
Donghwan Kim South Korea
Leilei Wu China
Xiaofeng Wu China
Chun A. Changou Taiwan
Lili Wang China
Sander H. Diks Netherlands
Johannes F. W. Greiner Germany
Petra Obexer Austria
Renping Zhao China
Shuping Li relative to Donghwan Kim South Korea Donghwan Kim's profile →
Citations per field
00.5×1.5×2.1×
Donghwan Kim · 1×
Citations per year

Countries citing papers authored by Shuping Li

Since Specialization
Citations

This map shows the geographic impact of Shuping Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuping Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuping Li more than expected).

Fields of papers citing papers by Shuping Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuping Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuping Li. The network helps show where Shuping Li may publish in the future.

Co-authorship network of co-authors of Shuping Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shuping Li. A scholar is included among the top collaborators of Shuping Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuping Li. Shuping Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 1
4 2
5 4
6 16
7 15
8 7
9 106
10 4
11 6
12 3
13 1
14 8
15 19
16 28
17 132
18
Community Structure and Species Diversity of ant in Luoyang Henan
1
19
Investigation of the Ants in Jiyuan Macaque Nature Reserve of Henan Province
1
20 3

About Shuping Li

Shuping Li is a scholar working on Cancer Research, Molecular Biology and Pharmacology, having authored 71 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (8 papers), Circular RNAs in diseases (8 papers) and MicroRNA in disease regulation (7 papers). The work is most often cited by research in Cancer Research (348 citations), Molecular Biology (778 citations) and Biological Psychiatry (17 citations). Shuping Li has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Guo‐fu Hu, Guo-fu Hu, Wenhao Yu, Soichiro Ibaragi, Ruidong Ma, Changhong Wang, Xuemei Cheng, Haiyan Liu, Zheng Zhao and Xiaobing Lv. Their work appears in journals such as Nature Communications, Blood and Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026